BigBear.ai (BBAI) Q1 2026 earnings review
GenAI Margins Masked by SG&A Bloat and Shareholder Dilution
BigBear.ai's Q1 2026 results present a stark contrast between operational capabilities and corporate cost control. The integration of the Ask Sage GenAI platform drove a massive, reversing acceleration in gross margins, leaping from 21.3% a year ago to 34.0%. However, this software-driven profitability never reached the bottom line. SG&A expenses ballooned by 28% YoY to $29.2M, dragging Adjusted EBITDA further into negative territory at $(9.9)M. Management touts a strong balance sheet with $431.5M in liquidity and eliminated debt, but this was achieved through catastrophic shareholder dilution—share count nearly doubled YoY. While a $53M classified defense win shows the product works, the current cost structure makes the stock uninvestable until operating leverage materializes.
🐂 Bull Case
The Ask Sage acquisition immediately transformed the margin profile. A 1,278 basis point jump in gross margins proves BigBear can sell high-margin GenAI platforms rather than just low-margin government services.
Total liquidity sits at a record $431.5M, and the toxic 2029 Convertible Notes were fully settled in January 2026, cutting interest expense by $4.8M YoY. Bankruptcy risk is off the table.
🐻 Bear Case
Despite adding $4.3M in gross profit YoY, SG&A grew by $6.5M. If a 13-point gross margin expansion still leads to a worsening Adjusted EBITDA, the underlying business model is fundamentally misaligned.
The 'clean balance sheet' was purchased with aggressive equity issuance. Basic shares outstanding jumped from 252 million in 25Q1 to 473 million in 26Q1, severely capping per-share upside.
⚖️ Verdict: 🔴
Bearish. The product-market fit in Defense and GenAI is evident, but a 28% surge in SG&A against a 1% decline in revenue is an unacceptable financial trajectory. Dilution has destroyed historical shareholder value.
Key Themes
Ask Sage Transforms Margin Profile
The most positive data point in the release is the reversing trend in gross profitability. Gross margins accelerated dramatically to 34.0%, up from 21.3% last year. Management explicitly attributes this to the mix shift toward Ask Sage's Generative AI platforms, confirming the thesis that BigBear can transition from a body-shop contractor to a high-margin software provider.
SG&A Bloat Destroys Operating Leverage
The margin victory was entirely squandered by corporate overhead. SG&A hit $29.2M in the quarter (85% of total revenue), driven by Ask Sage intangible amortization, legal/proxy fees, and expanding the sales team. The trajectory is stable but highly negative: the company is spending roughly $1.20 to generate $1.00 of revenue.
The Illusion of Backlog Growth
Management's PR highlighted a 14% sequential increase in backlog to $281.9M. However, looking at the prior year contradicts this rosy narrative. In Q1 2025, backlog was $385M. This means that despite the sequential bump from a $53M classified award, the overall backlog trajectory is severely decelerating/reversing YoY, indicating a massive long-term pipeline contraction.
National Security Demand is Real
The company booked close to $75M in wins in Q1, anchored by a $53M sole-source prime classified award. This validates CEO Kevin McAleenan's strategy to hyper-focus on National Security and Trade & Travel. Landing a sole-source contract of this size in the defense sector indicates high customer trust and unique, irreplaceable tech capabilities.
Historic Shareholder Dilution
BigBear fixed its debt problem by aggressively issuing equity. Over the past 12 months, the weighted-average basic shares outstanding exploded from 252 million to 473 million. While this eliminated the 2029 Notes and saved $4.8M in quarterly interest, the 87% dilution creates a massive overhang for any future earnings per share.
Other KPIs
Stable and highly liquid. This is up slightly from $415M at the end of FY25, providing a massive runway for M&A or organic burn. This war chest was accumulated through aggressive ATM stock offerings throughout 2025.
Decelerating loss compared to $(62.0) million in 25Q1. However, the improvement was largely driven by non-operating accounting noise: a $13.2M favorable variance in the fair value of derivatives, offset by a $13.2M non-cash loss on the extinguishment of debt.
Guidance
Stable. Management affirmed this full-year range. At the midpoint ($150M), this implies an accelerating growth rate of ~17% YoY compared to the estimated $128M generated in FY25. Given Q1 delivered $34.4M, the company must average roughly $38.5M per quarter for the rest of the year to hit the midpoint, requiring execution on the new $53M backlog win.
Key Questions
Path to Operating Leverage
Gross margins expanded by nearly 1,300 basis points due to Ask Sage, yet Adjusted EBITDA worsened. At what specific revenue run-rate do you expect gross profit dollars to outpace the structural SG&A bloat required to run this business?
Backlog Discrepancy
You highlighted a 14% sequential increase in backlog to $281.9 million. However, backlog was $385 million in Q1 of last year. Can you bridge the $100M+ year-over-year gap and explain if win rates or contract durations are shrinking?
Capital Allocation Strategy
With $431 million in liquidity and the 2029 notes extinguished, the balance sheet is secure. Are you planning further dilution via ATM facilities this year, or is the current capital sufficient to reach cash flow breakeven?